Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd
688336
Peringkat dalam Saham
#3774
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd functions as a... Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd functions as a biopharmaceutical enterprise operating in China. This company is thoroughly engaged in the full lifecycle of antibody-based medicines, from their initial research and development to their production and subsequent market introduction. Its current portfolio includes YISAIPU, a tumor necrosis factor inhibitor utilized for treating rheumatic ailments; Xenopax, a recombinant humanized anti-CD25 monoclonal antibody delivered via injection; and Cipterbin, an anti-HER2 monoclonal antibody. Furthermore, the organization is actively progressing novel treatments designed for autoimmune disorders, various cancers, and other health issues. Established in 2002, its main offices are situated in Shanghai, China.
Harga Saham
$4.87
Kapitalisasi Pasar
$4.36B
Perubahan (1 hari)
-5.47%
Perubahan (1 tahun)
-15.62%
Negara
CN
Perdagangan Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd (688336)
Kategori
Healthcare
Riwayat pemecahan saham untuk Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd (688336)
Saham Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd (simbol: 688336) telah mengalami total 1 kali pemecahan saham.
Pemecahan saham terbaru terjadi pada Jun 18, 2026.
Satu lembar saham 688336 yang dibeli sebelum Jun 18, 2026 sekarang setara dengan 1.45 lembar saham 688336.
Pemecahan saham terbaru terjadi pada Jun 18, 2026.
Satu lembar saham 688336 yang dibeli sebelum Jun 18, 2026 sekarang setara dengan 1.45 lembar saham 688336.
Daftar pemecahan saham
| Tahun | Pemecahan | Kelipatan | Kelipatan Kumulatif |
|---|---|---|---|
| 2026-06-18 | 29:20 | x1.45 | x1.45 |
Pemecahan saham untuk perusahaan sejenis atau pesaing
| Perusahaan | Jumlah pemecahan saham | Kelipatan Kumulatif | Negara |
|---|---|---|---|
| 1 | x2 |
US
|
|
| 0 | - |
US
|
|
| 1 | x3 |
AU
|
|
| 1 | x100 |
BE
|
|
| 0 | - |
NL
|
